Plasminogen activator inhibitor-1 (PAI-1) - pathogenetic role in coronary disease

被引：0
作者：
Mlynarska, Agata [1 ]
Waszyrowski, Tomasz [1 ]
Kasprzak, Jaroslaw D. [2 ]
机构：
[1] III Szpital Miejski Dr K Jonschera, Oddial Kardiol, PL-93113 Lodz, Poland
[2] Uniwersytet Medy, Katedra Kardiol 2, Lodz, Poland
来源：
KARDIOLOGIA POLSKA | 2007年 / 65卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1109 / 1114
页数：6
相关论文
共 50 条
  • [31] ISOLATION AND CHARACTERIZATION OF REACTIVATED FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1)
    DECLERCK, PJ
    DEMOL, M
    COLLEN, D
    THROMBOSIS AND HAEMOSTASIS, 1991, 65 (06) : 653 - 653
  • [32] Plasminogen Activator Inhibitor-1 (PAI-1) is an Essential Driver of Cardiovascular Aging in Mice
    Kalousdian, Anthony
    Soberanes, Saul
    Eren, Mesut
    Jorgensen, Emily
    Lux, Elizabeth
    Wilsbacher, Lisa D.
    Vaughan, Douglas E.
    CIRCULATION, 2023, 148
  • [33] GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) LOCUS
    DAWSON, S
    HAMSTEN, A
    WIMAN, B
    HENNEY, A
    HUMPHRIES, S
    FIBRINOLYSIS, 1990, 4 : 51 - 53
  • [34] MOLECULAR-FORMS OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN PLASMA
    ALESSI, MC
    JUHANVAGUE, I
    DECLERCK, PJ
    COLLEN, C
    THROMBOSIS AND HAEMOSTASIS, 1989, 62 (01) : 475 - 475
  • [35] Induction of conformational changes within crystals of plasminogen activator inhibitor-1 (PAI-1)
    Willems, PKA
    Gils, A
    Aertgeerts, K
    De Ranter, CJ
    Declerck, PJ
    FIBRINOLYSIS & PROTEOLYSIS, 1999, 13 (4-5): : 203 - 207
  • [36] Plasminogen activator inhibitor-1 (PAI-1) polymorphisms in patients with obstructive sleep apnoea
    Barceló, A
    Llompart, E
    Barbé, F
    Morlá, M
    Vila, M
    Agustí, AGN
    RESPIRATORY MEDICINE, 2002, 96 (03) : 193 - 196
  • [37] ACTIVITY OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) IN A POPULATION OF NORTHERN SWEDEN
    RANBY, M
    SUNDELL, IB
    JOHNSON, O
    LEDIN, MC
    DAHLEN, G
    FIBRINOLYSIS, 1990, 4 : 54 - 55
  • [38] Cardioprotective potential of plasminogen activator inhibitor-1 (PAI-1) in human inflammatory cardiomyopathy
    Baumeier, C.
    Escher, F.
    Aleshcheva, G.
    Pietsch, H.
    Schultheiss, H. P.
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 : 320 - 320
  • [39] Plasminogen Activator Inhibitor-1 (PAI-1) deficiency predisposes to depression and resistance to treatments
    Party, Helene
    Dujarrier, Cleo
    Hebert, Marie
    Lenoir, Sophie
    Martinez de Lizarrondo, Sara
    Delepee, Raphael
    Fauchon, Claudine
    Bouton, Marie-Christine
    Obiang, Pauline
    Godefroy, Olivier
    Save, Etienne
    Lecardeur, Laurent
    Chabry, Joelle
    Vivien, Denis
    Agin, Veronique
    ACTA NEUROPATHOLOGICA COMMUNICATIONS, 2019, 7 (01)
  • [40] The Synergistic Effect of Plasminogen Activator Inhibitor-1 (PAI-1) Polymorphisms and Metabolic Syndrome on Coronary Artery Disease in the Korean Population
    Park, Han Sung
    Sung, Jung-Hoon
    Ryu, Chang Soo
    Lee, Jeong Yong
    Ko, Eun Ju
    Kim, In Jai
    Kim, Nam Keun
    JOURNAL OF PERSONALIZED MEDICINE, 2020, 10 (04): : 1 - 13
12345